Table 2.
GEE Logistic Model of Heavy Alcohol Use Over the Next Week (N=1350)
| B | SEB | OR | Lower 95% CI | Upper 95% CI | p | |
|---|---|---|---|---|---|---|
| Age | −.01 | .00 | 0.99 | 0.98 | 1.00 | .01 |
| Gender (reference = male) | −.02 | .09 | 0.98 | 0.82 | 1.17 | .84 |
| Treatment (reference = Pill placebo) | ||||||
| Acamprosate | .10 | .32 | 1.11 | 0.59 | 2.07 | .77 |
| Naltrexone | −.17 | .31 | 0.84 | 0.46 | 1.55 | .59 |
| Acamprosate+naltrexone | −.70 | .33 | 0.50 | 0.26 | 0.95 | .03 |
| Pill placebo+CBT | −.11 | .31 | 0.90 | 0.49 | 1.64 | .73 |
| Acamprosate+CBT | −.12 | .30 | 0.89 | 0.49 | 1.60 | .69 |
| Naltrexone+CBT | −.02 | .32 | 0.98 | 0.52 | 1.84 | .96 |
| Acamprosate+naltrexone+CBT | −.25 | .34 | 0.78 | 0.40 | 1.52 | .46 |
| CBT | .19 | .32 | 1.21 | 0.65 | 2.26 | .55 |
| Site (reference =1) | ||||||
| 2 | −.31 | .19 | 0.73 | 0.51 | 1.06 | .10 |
| 3 | .00 | .10 | 1.00 | 0.82 | 1.21 | .99 |
| 4 | −.22 | .17 | 0.80 | 0.58 | 1.12 | .23 |
| 5 | −.64 | .21 | 0.53 | 0.35 | 0.80 | .00 |
| 6 | −.31 | .19 | 0.73 | 0.51 | 1.06 | .11 |
| 7 | −.72 | .19 | 0.49 | 0.34 | 0.71 | <.001 |
| 8 | .01 | .18 | 1.01 | 0.71 | 1.43 | .98 |
| 9 | −.09 | .17 | 0.91 | 0.65 | 1.28 | .57 |
| 10 | −.44 | .18 | 0.64 | 0.45 | 0.92 | .02 |
| 11 | −.42 | .18 | 0.66 | 0.46 | 0.94 | .02 |
| Heavy alcohol use previous week | 2.84 | .17 | 17.12 | 12.27 | 23.88 | <.001 |
| Time | −.05 | .03 | 0.95 | 0.90 | 1.01 | .18 |
| Craving Scale | .25 | .05 | 1.28 | 1.16 | 1.42 | <.001 |
| Craving Scale X heavy alcohol use previous week | −.10 | .03 | 0.90 | 0.85 | 0.96 | .00 |
Note. Non-significant interaction terms for Craving Scale by Time (Wald Chi-Square=3.10, p=.08), Craving Scale by Treatment (Wald Chi-Square=5.73, p =.68), and Craving Scale by Treatment by Time (Wald Chi-Square=11.00, p=.20) are not presented in the table. OR=odds ratio; CI=Confidence Interval; CBT=cognitive behavioral therapy.